| Literature DB >> 19498434 |
Abstract
In light of claims of improved efficacy and lower incidence of adverse effects compared with older drugs, second-generation antipsychotics have emerged as the predominant treatment for schizophrenia. A new meta-analysis concludes that the difference in efficacy between newer and older agents is small, and the current classification scheme for antipsychotics does not survive close scrutiny.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19498434 DOI： 10.1038/nrneurol.2009.68
Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937